White label – Pompe disease - ClinicalTrials.eu

Study of inhaled LTI-03 for safety and effectiveness in patients with Idiopathic Pulmonary Fibrosis who may be receiving standard antifibrotic therapy

Recruiting

2 1
Investigated Drugs:
- LTI-03
Study of fixed-dose follitropin delta for ovarian stimulation in women undergoing intrauterine insemination treatment for infertility

Recruiting

2 1 1 1
Investigated Drugs:
Study of RO7837195 injection compared to placebo to treat moderate to severe ulcerative colitis

Recruiting

2 1
Investigated Drugs:
- RO7837195
Study of ivonescimab with chemotherapy combination for first and second-line treatment in patients with advanced or metastatic gastric and gastroesophageal cancer

Recruiting

2 1 1 1
Investigated Diseases:
- Gastric cancer stage IV
- Oesophageal carcinoma
Investigated Drugs:
Study of metformin for cancer prevention in adolescents and adults with Li-Fraumeni syndrome

Recruiting

3 1 1 1
Investigated Drugs:
- Metformin
- Metformin Hydrochloride
Study of GSK5764227 alone and in combination for patients with previously treated advanced gastrointestinal tumors that cannot be removed by surgery or have spread

Recruiting

1 1 1
Investigated Diseases:
- Gastrointestinal carcinoma
Investigated Drugs:
- GSK5764227
+4
Study of patritumab deruxtecan versus drug combination in patients with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer

Recruiting

3 1 1 1
Investigated Diseases:
- Hormone receptor positive HER2 negative breast cancer
- Hormone receptor positive breast cancer
Investigated Drugs:
+1
Study of ELA026 for Treatment of Secondary Hemophagocytic Lymphohistiocytosis in Patients with Lymphoma Who Have Not Received Previous Treatment

Recruiting

4 1 1
Study of intravenous melatonin safety and dosing in newborns with moderate to severe hypoxic-ischaemic encephalopathy receiving therapeutic hypothermia treatment

Recruiting

1 1 1
Investigated Drugs:
- Melatonin
Study of NBI-1065845 as add-on treatment to prevent depression relapse in adults with Major Depressive Disorder who responded to initial treatment

Recruiting

3 1
Investigated Diseases:
- Major depression
Investigated Drugs:
- 9-(4-CYCLOHEXYLOXYPHENYL)-7-METHYL-3,4-DIHYDROPYRAZINO[2,1-C][1,2,4]THIADIAZINE 2,2-DIOXIDE

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies